U.S. Online Retail and Ecommerce Stock News

NasdaqGS:ADPT
NasdaqGS:ADPTLife Sciences

Adaptive Biotechnologies (ADPT) Q4 Loss Narrows Yet Premium Valuation Tests Bullish Narratives

Adaptive Biotechnologies (ADPT) closed out FY 2025 with Q4 revenue of US$71.7 million and a basic EPS loss of US$0.09, alongside net income excluding extra items of a US$13.6 million loss. This provides a clear snapshot of where the business stands after a volatile year. The company reported revenue of US$47.5 million in Q4 2024 and US$71.7 million in Q4 2025, while basic EPS moved from a loss of US$0.23 to a loss of US$0.09 over the same period. This places the focus on how far these revenue...
NYSE:EL
NYSE:ELPersonal Products

Estée Lauder (EL) Returns To Quarterly Profit With US$0.45 EPS Challenging Bearish Narratives

Estée Lauder Companies (EL) just posted Q2 2026 results with revenue of US$4.2 billion and basic EPS of US$0.45, alongside net income of US$162 million, putting the latest quarter firmly back in profit territory. Over the past few quarters, revenue has moved from US$3.4 billion in Q1 2025 and US$4.0 billion in Q2 2025 to US$3.5 billion in Q3 2025, US$3.4 billion in Q4 2025, US$3.5 billion in Q1 2026, and now US$4.2 billion in Q2 2026. Basic EPS has ranged from losses of US$1.64 in Q2 2025 and...
NasdaqGS:MSTR
NasdaqGS:MSTRSoftware

MicroStrategy (MSTR) Q4 Loss Of US$42.93 Per Share Tests Profitability Narratives

Strategy (MSTR) closed out FY 2025 with fourth quarter revenue of US$123 million and a basic EPS loss of US$42.93. Trailing twelve month figures show revenue of US$477 million and a basic EPS loss of US$15.23. Over recent quarters, the company has seen quarterly revenue move from US$111 million in Q1 2025 to US$128.7 million in Q3 2025 before landing at US$123 million in Q4. This was alongside basic EPS swinging from a loss of US$16.47 in Q1 to a profit of US$36.23 in Q2 and back to a loss in...
NYSE:EQR
NYSE:EQRResidential REITs

Equity Residential (EQR) Steady FFO Undercuts Bearish Narratives On Earnings Sustainability

Equity Residential (EQR) has wrapped up FY 2025 with fourth quarter revenue of US$781.9 million and basic EPS of US$1.01, alongside funds from operations of US$376.8 million that remain a key gauge for this residential REIT. Over the past few quarters, the company has seen revenue move from US$766.8 million in Q4 2024 to US$781.9 million in Q4 2025. Trailing twelve month basic EPS was US$2.95 and net income reached about US$1.1 billion, which may lead investors to focus on how margins and...
NasdaqGS:ARWR
NasdaqGS:ARWRBiotechs

Arrowhead Pharmaceuticals (ARWR) Q1 Profit Challenges Bearish Narratives On Earnings Quality

Arrowhead Pharmaceuticals (ARWR) has opened fiscal 2026 with Q1 revenue of US$264.0 million and basic EPS of US$0.22, supported by net income of US$30.8 million as the company continues to build on its move into profitability over the past year. Over recent quarters, revenue has shifted from US$2.5 million in Q1 2025 to US$542.7 million in Q2 2025, US$27.8 million in Q3 2025, US$256.5 million in Q4 2025, and now US$264.0 million in Q1 2026. EPS has moved from a loss of US$1.39 per share in Q1...
NYSE:DLR
NYSE:DLRSpecialized REITs

Digital Realty Trust (DLR) FFO Stability Reinforces Bullish Narratives Despite One Off Earnings Boost

Digital Realty Trust (DLR) closed out FY 2025 with Q4 revenue of US$1.6b and basic EPS of US$0.26, while funds from operations reached US$657.9m, giving investors a clear read on both top line scale and REIT specific cash generation. Over the last few quarters, the company has seen revenue move from US$1.40b in Q4 2024 to US$1.64b in Q3 2025 and then to US$1.64b in Q4 2025, with basic EPS ranging from US$0.54 in Q4 2024 to US$0.17 in Q3 2025 and US$0.26 in Q4 2025. With trailing twelve month...
NYSE:CNC
NYSE:CNCHealthcare

Centene (CNC) Swings To US$6.7b TTM Loss Challenging Bullish Margin Recovery Narratives

Centene (CNC) just closed out FY 2025 with Q4 revenue of US$45.1b and a basic EPS loss of US$2.24, capping a trailing twelve month period where revenue reached US$176.2b and basic EPS stood at a loss of US$13.53. The company has seen quarterly revenue move from US$36.6b in Q4 2024 and US$37.3b in Q3 2024 to the current US$45.1b and US$45.3b in Q4 and Q3 2025. Over the same periods, EPS shifted from US$0.57 and US$1.37 in those 2024 quarters to losses of US$2.24 and US$13.50 in the latest 2025...
NYSE:WEC
NYSE:WECIntegrated Utilities

WEC Energy Group (WEC) Margin Slippage Tests Steady Utility Earnings Narrative

WEC Energy Group (WEC) closed out FY 2025 with fourth quarter revenue of US$2.5b and basic EPS of US$0.97, supported by net income of US$316.6m. The trailing twelve months show revenue of US$9.8b and EPS of US$4.84 on net income of US$1.56b. Over the past few quarters, the company has reported revenue in a range from US$2.0b to US$3.1b, and quarterly EPS between US$0.77 and US$2.28. Trailing twelve month revenue increased from US$8.6b in late 2024 to US$9.8b in late 2025. Taken together, the...
NYSE:BXMT
NYSE:BXMTMortgage REITs

Blackstone Mortgage Trust Link To Anthropic Lease And AI Office Demand

Blackstone Real Estate's joint venture has signed a full building lease with AI firm Anthropic in downtown San Francisco. The agreement covers a long term commitment in the emerging "AI Alley" district, one of the largest office leases in the city's history. The deal highlights demand from artificial intelligence companies for well located urban office space. For investors watching Blackstone Mortgage Trust (NYSE:BXMT), the Anthropic lease puts a spotlight on how Blackstone affiliated real...
NYSE:ORC
NYSE:ORCMortgage REITs

Will Orchid Island Capital's (ORC) 2025 EPS Surge Without Buybacks Change Its Investment Narrative?

Orchid Island Capital, Inc. reported its fourth-quarter and full-year 2025 results on January 29, 2026, with net income rising to US$103.41 million for the quarter and US$159.03 million for the year, alongside basic and diluted earnings per share of US$0.62 for the quarter and US$1.24 for the year. An interesting angle for investors is that these higher earnings came without additional share repurchases in the fourth quarter, leaving the long-running buyback program largely completed but...
NasdaqGS:FTNT
NasdaqGS:FTNTSoftware

Fortinet (FTNT) Margin Decline Challenges Bullish Earnings Growth Narratives

Fortinet (FTNT) has wrapped up FY 2025 with fourth quarter revenue of about US$1.9b and basic EPS of US$0.68, alongside net income excluding extra items of US$506m. This gives investors a clear read on its recent trading momentum. The company has seen quarterly revenue move from US$1.66b in Q4 2024 to US$1.91b in Q4 2025, while basic EPS shifted from US$0.69 to US$0.68 over the same period. This sets the scene for a year where margins and profit quality remain in sharp focus. See our full...
NasdaqGS:NEOG
NasdaqGS:NEOGMedical Equipment

Neogen Recall Puts Veterinary Quality Controls And Investor Confidence In Focus

Neogen Corporation initiated a voluntary recall of its HYCOAT Hyaluronate Sodium Sterile Solution used in veterinary settings. The recall was triggered by microbial contamination identified in certain product lots. The affected product is intended for animal use, and the company has reported adverse events in animals linked to the issue. Neogen is working with the U.S. Food and Drug Administration on the recall process. For investors tracking Neogen (NasdaqGS:NEOG), this recall comes at a...
NasdaqGM:UNB
NasdaqGM:UNBBanks

Union Bankshares (UNB) Earnings Growth And 20.6% Margin Challenge Bearish Narratives

Union Bankshares (UNB) closed FY 2025 with fourth quarter total revenue of US$14.1 million and basic EPS of US$0.60, alongside net income of US$2.7 million. On a trailing twelve month basis, revenue was US$53.7 million with EPS of US$2.43 and net income of US$11.1 million. Over the past year, the company has seen revenue move from US$47.2 million to US$53.7 million on a trailing basis, with EPS shifting from US$1.94 to US$2.43. This sets up a story where improving margins and a 20.6% trailing...
NYSE:BILL
NYSE:BILLSoftware

Bill Holdings Q2 Loss Challenges Bullish Narrative On Revenue Growth And Valuation Discount

BILL Holdings (BILL) just posted Q2 2026 results with revenue of US$414.7 million and a basic EPS loss of US$0.03, alongside net income excluding extra items of a US$2.6 million loss. The company has seen quarterly revenue move from US$362.6 million in Q2 2025 to US$414.7 million in Q2 2026, while basic EPS shifted from a profit of US$0.33 to a loss of US$0.03 over the same period. This puts the spotlight firmly on how efficiently that extra revenue is translating into margins. See our full...
NasdaqGS:SSNC
NasdaqGS:SSNCProfessional Services

SS&C Technologies (SSNC) Margin Holding Steady Keeps Premium P/E Narrative Intact

SS&C Technologies Holdings (SSNC) has wrapped up FY 2025 with Q4 revenue of US$1.65b and basic EPS of US$0.80, while trailing 12 month revenue sits at US$6.27b and EPS at US$3.26 as the company continues to post solid net income figures across the year. The company has seen revenue move from US$1.53b in Q4 2024 to US$1.65b in Q4 2025, with quarterly EPS shifting from US$1.01 to US$0.80 over the same period, giving investors a clear view of how top line expansion and per share earnings are...
NYSE:BMY
NYSE:BMYPharmaceuticals

Bristol Myers Squibb (BMY) Returns To US$7.1b Trailing Profit Challenging Bearish Narratives

Bristol Myers Squibb (BMY) closed out FY 2025 with Q4 revenue of US$12.5 billion and basic EPS of US$0.53, alongside net income of US$1,087 million, setting the tone for how investors will read the full year. Over the past few quarters, the company has seen revenue move from US$11.2 billion in Q1 2025 to a range of about US$12.2 billion to US$12.7 billion in Q2 through Q4. Quarterly basic EPS has ranged from US$0.64 to US$1.21 across the year, giving a clearer picture of how profits track...
NasdaqGS:CRTO
NasdaqGS:CRTOMedia

Assessing Criteo (CRTO) Valuation As It Rolls Out AI Agentic Commerce Recommendation Service

Criteo (CRTO) has launched its Agentic Commerce Recommendation Service, a new AI driven tool that connects shopping assistants and retailer chatbots to merchant inventory using real shopping behavior and transactional data. See our latest analysis for Criteo. For shareholders, the picture is mixed, with a 1-day share price return of 1.59%, a year-to-date share price return decline of 4.24%, and a 1-year total shareholder return decline of 57.82%. This suggests momentum has been fading even as...
NYSE:RXO
NYSE:RXOTransportation

RXO (RXO) Q4 Loss Deepens To US$46m And Tests Rapid Earnings Growth Narrative

RXO (RXO) closed out FY 2025 with Q4 revenue of US$1.5b, a basic EPS loss of US$0.27 and net income loss of US$46m. This sits against a trailing twelve month picture of US$5.7b in revenue, a basic EPS loss of US$0.59 and a net income loss of US$100m. The company reported quarterly revenue in a tight band between US$1.4b and US$1.5b through FY 2025, while quarterly EPS losses ranged from US$0.05 to US$0.27 and net income losses moved between US$9m and US$46m. Altogether, these results point to...
NasdaqGS:QNST
NasdaqGS:QNSTInteractive Media and Services

QuinStreet (QNST) EPS Surge To US$0.88 Tests Bearish Earnings Decline Narrative

QuinStreet (QNST) has just posted Q2 2026 results with revenue of US$287.8 million and basic EPS of US$0.88, putting a spotlight on how its top and bottom lines are tracking after a year of swinging into profitability on a trailing basis. The company has seen quarterly revenue move from US$282.6 million in Q2 2025 to US$287.8 million in Q2 2026, while basic EPS has shifted from a US$0.03 loss to US$0.88 over the same period, giving investors a clearer view of how margins are now flowing...
NasdaqGS:BCRX
NasdaqGS:BCRXBiotechs

BioCryst Uses Equity Grants To Support Rare Disease Pipeline And Talent

BioCryst Pharmaceuticals (NasdaqGS:BCRX) granted inducement stock options and restricted stock units to 24 newly hired employees. The equity awards are part of the company’s talent acquisition and retention program and were approved in connection with these hires. BioCryst focuses on treatments for rare diseases and infectious conditions, areas that often require specialized expertise and long development cycles. Bringing in 24 new employees with equity incentives indicates that the company...
NYSE:ATR
NYSE:ATRPackaging

AptarGroup (ATR) Slower 4.9% Earnings Growth Tests Long Term Bullish Narrative

AptarGroup’s FY 2025 Earnings Set Against Easing Growth Momentum AptarGroup (ATR) closed FY 2025 with fourth quarter revenue of US$962.7 million and basic EPS of US$1.14, compared with US$848.1 million and EPS of US$1.52 in the same quarter a year earlier. Trailing twelve month EPS for Q4 stood at US$5.97 on revenue of US$3.8 billion. Over the last 12 months, earnings growth of 4.9% sat below the 13.3% five year pace and came alongside a net profit margin of 10.4% versus 10.5% the prior year...
NYSE:UAA
NYSE:UAALuxury

Under Armour (UAA) Q3 EPS Loss Deepens And Tests Bullish Earnings Recovery Narratives

Under Armour (UAA) has just posted Q3 2026 results with revenue of US$1.3 billion and a basic EPS loss of US$1.01, as the company continues to work through an unprofitable stretch. Over recent quarters, revenue has moved between US$1.1 billion and US$1.4 billion, while basic EPS has ranged from a small profit of roughly zero to a loss of just over US$1.01. This has prompted investors to focus less on top line stability and more on how quickly margins can be repaired from here. See our full...
NasdaqGS:SWKS
NasdaqGS:SWKSSemiconductor

Skyworks Solutions Q1 2026 Margin Compression Rekindles Bearish Narratives On Earnings Power

Skyworks Solutions (SWKS) Q1 2026 earnings snapshot Skyworks Solutions (SWKS) opened fiscal Q1 2026 with revenue of US$1.0 billion and basic EPS of US$0.53, alongside net income of US$79.2 million, setting a measured tone for the new financial year. The company has seen quarterly revenue move from US$1.03 billion in Q4 2024 to US$1.10 billion in Q4 2025 and then to US$1.04 billion in Q1 2026, while EPS has ranged from US$0.38 in Q4 2024 to US$1.01 in Q1 2025 and US$0.53 in the latest quarter...
NYSE:KRP
NYSE:KRPOil and Gas

Is Kimbell Royalty Partners (KRP) Pricing Reflecting Its Recent Strong Unit Performance

If you are wondering whether Kimbell Royalty Partners at around US$13.79 is offering fair value or an opportunity, you are in the right place. The units have returned 2.7% over the last 7 days, 19.9% over the last 30 days, 14.6% year to date, 0.6% over 1 year, 21.5% over 3 years and 139.3% over 5 years, which raises fresh questions about how much is already reflected in the current price. Recent attention on Kimbell Royalty Partners has centered on its position in the US energy royalty space...